Pekka Haapaniemi

- Research Technician,
Turku Bioscience Centre (Independent units)

pekka.haapaniemi@bioscience.fi

+358 29 450 2200

+358 50 383 1782

Tykistökatu 6

Turku

: +358 503831782

Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin. (2025)
- British Journal of Cancer
Kallionpää, Roope A.; Martikkala, Eija; Haapaniemi, Pekka; Karppinen, Sanna-Maria; Riihilä, Pilvi; Rokka, Anne; Leivo, Ilmo; Pihlajaniemi, Taina; Peltonen, Sirkku; Peltonen, Juha
Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1 (2024)
- Laboratory Investigation
Kallionpää Roope A., Peltonen Sirkku, Le Kim My, Martikkala Eija, Jääskeläinen Mira, Fazeli Elnaz, Riihilä Pilvi, Haapaniemi Pekka, Rokka Anne, Salmi Marko, Leivo Ilmo, Peltonen Juha
Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia (2022)
- Cancers
Oksa Laura, Mäkinen Artturi, Nikkilä Atte, Hyvärinen Noora, Laukkanen Saara, Rokka Anne, Haapaniemi Pekka, Seki Masafumi, Takita Junko, Kauko Otto, Heinäniemi Merja, Lohi Olli
Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1 (2022)
- Dermatology
Kallionpää Roope A, Ahramo Kaisa, Martikkala Eija, Fazeli Elnaz, Haapaniemi Pekka, Rokka Anne, Leivo Ilmo, Harvima Ilkka T, Peltonen Juha, Peltonen Sirkku
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1 (2020)
- Journal of Biological Chemistry
Kauko O, Imanishi SY, Kulesskiy E, Yetukuri L, Laajala TD, Sharma M, Pavic K, Aakula A, Rupp C, Jumppanen M, Haapaniemi P, Ruan L, Yadav B, Suni V, Varila T, Reimand J, Corthals GL, Aittokallio T, Wennerberg K, Westermarck J
Optimization of TripleTOF spectral simulation and library searching for confident localization of phosphorylation sites (2019)
- PLoS ONE
Takai A., Tsubosaka T., Hirano Y., Hayakawa N., Tani F., Haapaniemi P., Suni V., Imanishi S.
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells (2018)
- Science Translational Medicine
Otto Kauko, Caitlin M. O’Connor, Evgeny Kulesskiy, Jaya Sangodkar, Anna Aakula, Sudeh Izadmehr, Laxman Yetukuri, Bhagwan Yadav, Artur Padzik, Teemu Daniel Laajala, Pekka Haapaniemi, Majid Momeny, Taru Varila, Michael Ohlmeyer, Tero Aittokallio, Krister Wennerberg, Goutham Narla, Jukka Westermarck
Quantitative Site-Specific Phosphoproteomics of Trichoderma reesei Signaling Pathways upon Induction of Hydrolytic Enzyme Production (2016)
- Journal of Proteome Research
Elizabeth Vi Nguyen, Susumu Y. Imanishi, Pekka Haapaniemi, Avinash Yadav, Markku Saloheimo, Garry L. Corthals, Tiina M Pakula
Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling (2015)
- Scientific Reports
Otto Kauko, Teemu Daniel Laajala, Mikael Jumppanen, Petteri Hintsanen, Veronika Suni, Pekka Haapaniemi, Garry Corthals, Tero Aittokallio, Jukka Westermarck, Susumu Y. Imanishi